Orris

Give me a very standard informative note about chronic liver disease with clinical features, etiology ,presentations , physiology, pathology , pharmacology,complications , management principles , treatment and follow up , refer all the top sources including kumar and Clark11th edition , I’m a gold medal student

Reading File
Finding Sources
Finding Sources
Searching PubMed

"chronic liver disease" OR "cirrhosis" AND management

Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Searching the Web

EASL AASLD chronic liver disease cirrhosis management guidelines 2024 2025

This is a gold-medal standard, exhaustive clinical note on Chronic Liver Disease. Here's a summary of what's covered and key points to remember:
What's in this note (at a glance):
  1. Definition - CLD vs. cirrhosis distinction; >6 months, progressive
  2. Etiology - Full table of common (ALD, HBV, HCV, MASLD, AIH) and rare causes (hemochromatosis, Wilson's, A1AT, PSC, PBC, drugs, cardiac)
  3. Pathology - Macro (micro/macronodular), micro (METAVIR F0-F4), cellular mechanisms via hepatic stellate cells (HSC), TGF-β1, PDGF, fibrosis reversibility
  4. Physiology/Pathophysiology - Portal hypertension mechanisms (fixed + dynamic resistance; hyperdynamic circulation; peripheral vasodilation theory); RAAS/SNS/ADH activation; ascites formation
  5. Clinical Features - Compensated vs. decompensated; full sign table (spider naevi, palmar erythema, caput medusae, etc.); endocrine signs; ABCDE of decompensation
  6. Investigations - LFTs (with ranges), fibrosis scoring (FIB-4, APRI, Fibroscan), Child-Pugh table, MELD score formula
  7. Complications - Varices, ascites/SBP, hepatic encephalopathy (West Haven grading + precipitants), HRS (Type 1/2), HPS, HCC, coagulopathy, bone disease, cirrhotic cardiomyopathy
  8. Pharmacology - Disease-specific drugs (DAAs, entecavir, UDCA, venesection), variceal drugs (terlipressin, β-blockers, octreotide), ascites/HRS drugs (spironolactone, furosemide, albumin, terlipressin), HE drugs (lactulose, rifaximin, LOLA, BCAAs), SBP treatment/prophylaxis, contraindicated drugs
  9. Management - Step-wise protocols for varices (primary prophylaxis → acute bleed → secondary), ascites, HE, HRS; BCLC staging for HCC; Milan criteria for transplant
  10. Follow-up - Compensated vs. decompensated schedules; post-transplant monitoring
  11. Prognosis - Survival tables by Child-Pugh, MELD, and individual complications

Thanks

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.
This is a shared conversation. Sign in to Orris to start your own chat.